Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis

Journal of Investigative Dermatology

Volumn 133, Issue 1, 2013, Pages 230-238

  Bracher, Andreas ^a   Cardona, Ana Soler ^a   Tauber, Stefanie ^a,b   Fink, Astrid M ^c   Steiner, Andreas ^d   Pehamberger, Hubert ^a   Niederleithner, Heide ^a   Petzelbauer, Peter ^a   Gröger, Marion ^a   Loewe, Robert ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MAX F PERUTZ LABORATORIES   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; IN VIVO STUDY; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MELANOMA CELL; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; TUMOR XENOGRAFT;

EID: 84872197738     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.272     Document Type: Article

References (41)

1. Alders M, Hogan BM, Gjini E et al. (2009) Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 41:1272-44
2. Amin DN, Hida K, Bielenberg DR et al. (2006) Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors. Cancer Res 66:2173-800
3. Avraamides CJ, Garmy-Susini B, Varner JA (2008) Integrins in angiogenesis and lymphangiogenesis. Nat Rev Cancer 8:604-177
4. Avraham R, Yarden Y (2011) Feedback regulation of EGFR signalling: Decision making by early and delayed loops. Nat Rev Mol Cell Biol 12:104-177
5. Baker CH, Kedar D, McCarty MF et al. (2002) Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas. Am J Pathol 161:929-388
6. Cascone T, Herynk MH, Xu L et al. (2011) Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitorresistant human lung adenocarcinoma. J Clin Invest 121:1313-288
7. Dadras SS, Lange-Asschenfeldt B, Velasco P et al. (2005) Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol 18:1232-422
8. Dadras SS, Paul T, Bertoncini J et al. (2003) Tumor lymphangiogenesis: A novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol 162:1951-600
9. De Luca A, Carotenuto A, Rachiglio A et al. (2008) The role of the EGFR signaling in tumor microenvironment. J Cell Physiol 214:559-677
10. Dempsey PJ, Meise KS, Yoshitake Y et al. (1997) Apical enrichment of human EGF precursor in Madin-Darby canine kidney cells involves preferential basolateral ectodomain cleavage sensitive to a metalloprotease inhibitor. J Cell Biol 138:747-588
11. Emmett M, Symonds K, Rigby H et al. (2010) Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. BMC Cancer 10:2088
12. Enholm B, Paavonen K, Ristimaki A et al. (1997) Comparison of VEGF, VEGFB, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14:2475-833
13. Gallego E, Vicioso L, Alvarez M et al. (2011) Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas. Virchows Archiv 458:621-300
14. Glogowska A, Pyka J, Kehlen A et al. (2008) The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells. Neoplasia 10:1120-300
15. Gröger M, Loewe R, Holnthoner W et al. (2004) IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J Immunol 173:7161-99
16. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-700
17. Hardy K, Booth B, Hendrix M et al. (2010) ErbB/EGF signaling and EMT in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 15:191-99
18. Harris RC, Chung E, Coffey RJ (2003) EGF receptor ligands. Exp Cell Res 284:2-133
19. Hogan BM, Bos FL, Bussmann J et al. (2009) ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41:396-88
20. Kajanne R, Miettinen P, Mehlem A et al. (2007) EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J Cell Physiol 212:489-977
21. Kim HD, Meyer AS, Wagner JP et al. (2011) Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts. Mol Cell Proteomics 10:M111.008433-1-122
22. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9:302-122
23. Korff T, Kimmina S, Martiny-Baron G et al. (2001) Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15:447-577
24. Lafky JM, Wilken JA, Baron AT et al. (2008) Clinical implications of the ErbB// epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer. Biochimica et Biophysica Acta (BBA) Rev Cancer 1785:232-655
25. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-DeltaDeltaCT method. Methods 25:402-88
26. Loewe R, Holnthoner W, Gröger M et al. (2002) Dimethylfumarate inhibits TNF-induced nuclear entry of NF-{kappa}B/p65 in human endothelial cells. J Immunol 168:4781-77
27. Loewe R, Valero T, Kremling S et al. (2006) Dimethylfumarate impairs melanoma growth and metastasis. Cancer Res 66:11888-966
28. Luangdilok S, Box C, Harrington K et al. (2011) MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur J Cancer 47:520-99
29. Mascia F, Cataisson C, Lee TC et al. (2009) EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol 130:682-933
30. Maurer G, Tarkowski B, Baccarini M (2011) Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 30:3477-888
31. Mueller BM, Romerdahl CA, Trent JM et al. (1991) Suppression of spontaneous melanoma metastasis in SCID mice with an antibody to the epidermal growth factor receptor. Cancer Res 51:2193-88
32. Sibilia M, Wagner B, Hoebertz A et al. (2003) Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart. Development 130:4515-255
33. Singh AB, Harris RC (2005) Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 17:1183-933
34. Skobe M, Hawighorst T, Jackson DG et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-88
35. Steeg PS (2006) Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12:895-9044
36. Steeg PS, Camphausen KA, Smith QR (2011) Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 11:352-633
37. Trompezinski S, Berthier-Vergnes O, Denis A et al. (2004) Comparative expression of vascular endothelial growth factor family members, VEGFB, -C and -D, by normal human keratinocytes and fibroblasts. Exp Dermatol 13:98-1055
38. Valero T, Steele S, Neumü ller K et al. (2010) Combination of dacarbazine and dimethylfumarate efficiently reduces melanoma lymph node metastasis. J Invest Dermatol 130:1087-944
39. Yarden Y (2001) The EGFR family and its ligands in human cancer: Signalling mechanisms and therapeutic opportunities. Eur J Cancer 37:3-88
40. Yarden Y, Shilo BZ (2007) SnapShot: EGFR signaling pathway. Cell 131:10188
41. Zuo JH, Zhu W, Li MY et al. (2011) Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112:2508-177